EphAsad commited on
Commit
ed87bcf
·
verified ·
1 Parent(s): 25881ee

Update data/rag/knowledge_base/Borrelia/afzelii.json

Browse files
data/rag/knowledge_base/Borrelia/afzelii.json CHANGED
@@ -1,44 +1,99 @@
1
  {
 
 
2
  "genus": "Borrelia",
3
  "species": "afzelii",
4
- "full_name": "Borrelia afzelii",
5
- "clinical_significance": "One of the three main Borrelia burgdorferi sensu lato species causing Lyme borreliosis in Europe. Strongly associated with dermatologic manifestations, especially acrodermatitis chronica atrophicans and erythema migrans.",
6
- "phenotype_profile": {
7
- "morphology": "Loosely coiled spirochetes visible by dark-field microscopy or silver stain.",
8
- "culture": "Grows in BSK medium; slower than B. burgdorferi sensu stricto. No growth on standard media.",
9
- "biochemical": [
10
- "Oxidase negative",
11
- "Catalase negative",
12
- "ONPG negative",
13
- "Non-motile externally but highly motile via axial filaments",
14
- "No NaCl tolerance",
15
- "Microaerophilic"
16
- ]
17
  },
18
- "differentiation": {
19
- "from_close_species": [
20
- "More dermatotropic than B. burgdorferi s.s. or B. garinii.",
21
- "Less neuroinvasive than B. garinii.",
22
- "Common in central/northern Europe with Ixodes ricinus ticks."
 
 
 
 
 
 
23
  ],
24
- "from_other_genera": [
25
- "Spirochetal form excludes Anaplasma or Rickettsia.",
26
- "Cannot be seen on routine blood film unlike relapsing fever Borrelia."
27
- ]
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
28
  },
29
- "virulence_factors": [
30
- "Outer surface proteins (OspA/B/C) enabling tick and host colonization",
31
- "Immune evasion through variable VlsE expression"
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
32
  ],
33
- "confirmation_methods": [
34
- "PCR of skin biopsy or CSF",
35
- "Two-tier Lyme serology",
36
- "BSK medium culture (research use only)"
37
  ],
38
- "treatment_notes": "Responds to doxycycline, amoxicillin, cefuroxime. Longer treatments needed for skin or neurologic involvement.",
39
- "notes": "Major cause of acrodermatitis chronica atrophicans in Europe.",
40
- "references": [
41
- "European Lyme borreliosis guidelines",
42
- "Borrelia burgdorferi s.l. comparative genomics"
 
43
  ]
44
- }
 
1
  {
2
+ "schema_version": "1.0",
3
+ "level": "species",
4
  "genus": "Borrelia",
5
  "species": "afzelii",
6
+
7
+ "overview": {
8
+ "short": "Borrelia afzelii is a Lyme disease–associated spirochete prevalent in Europe.",
9
+ "clinical_context": "Frequently associated with chronic cutaneous manifestations such as acrodermatitis chronica atrophicans."
 
 
 
 
 
 
 
 
 
10
  },
11
+
12
+ "expected_fields": {
13
+ "Gram Stain": "Negative",
14
+ "Shape": "Spiral",
15
+ "Motility": "Positive",
16
+ "Capsule": "Negative",
17
+ "Spore Formation": "Negative",
18
+ "Haemolysis": "Negative",
19
+ "Haemolysis Type": "None",
20
+ "Media Grown On": [
21
+ "Barbour-Stoenner-Kelly Agar"
22
  ],
23
+ "Colony Morphology": [
24
+ "Not visible on routine media"
25
+ ],
26
+ "Oxygen Requirement": "Microaerophilic",
27
+ "Growth Temperature": "30//34",
28
+ "Catalase": "Negative",
29
+ "Oxidase": "Negative",
30
+ "Indole": "Negative",
31
+ "Urease": "Negative",
32
+ "Citrate": "Negative",
33
+ "Methyl Red": "Negative",
34
+ "VP": "Negative",
35
+ "H2S": "Negative",
36
+ "DNase": "Negative",
37
+ "ONPG": "Negative",
38
+ "Coagulase": "Negative",
39
+ "Gelatin Hydrolysis": "Negative",
40
+ "Esculin Hydrolysis": "Negative",
41
+ "Nitrate Reduction": "Negative",
42
+ "NaCl Tolerant (>=6%)": "Negative",
43
+ "Lipase Test": "Negative",
44
+ "Lysine Decarboxylase": "Negative",
45
+ "Ornithine Decarboxylase": "Negative",
46
+ "Ornitihine Decarboxylase": "Negative",
47
+ "Arginine dihydrolase": "Negative",
48
+ "Glucose Fermentation": "Negative",
49
+ "Lactose Fermentation": "Negative",
50
+ "Sucrose Fermentation": "Negative",
51
+ "Maltose Fermentation": "Negative",
52
+ "Mannitol Fermentation": "Negative",
53
+ "Sorbitol Fermentation": "Negative",
54
+ "Xylose Fermentation": "Negative",
55
+ "Rhamnose Fermentation": "Negative",
56
+ "Arabinose Fermentation": "Negative",
57
+ "Raffinose Fermentation": "Negative",
58
+ "Trehalose Fermentation": "Negative",
59
+ "Inositol Fermentation": "Negative",
60
+ "Gas Production": "Negative",
61
+ "TSI Pattern": "Unknown",
62
+ "Colony Pattern": "Unknown",
63
+ "Pigment": "None",
64
+ "Motility Type": "Axial Filaments"
65
  },
66
+
67
+ "species_markers": [
68
+ {
69
+ "field": "Geographic Distribution",
70
+ "value": "Europe",
71
+ "importance": "high",
72
+ "notes": "Predominantly European Lyme disease agent."
73
+ },
74
+ {
75
+ "field": "Clinical Manifestation",
76
+ "value": "Chronic cutaneous disease",
77
+ "importance": "medium",
78
+ "notes": "Skin involvement more common than neurologic disease."
79
+ }
80
+ ],
81
+
82
+ "common_confusions": [
83
+ {
84
+ "species": "Borrelia burgdorferi",
85
+ "reason": "Serologic cross-reactivity and overlapping Lyme disease features."
86
+ }
87
  ],
88
+
89
+ "when_to_question_identification": [
90
+ "Neurologic-dominant disease may suggest other Borrelia species."
 
91
  ],
92
+
93
+ "recommended_next_tests": [
94
+ {
95
+ "test": "PCR with species-specific primers",
96
+ "reason": "Differentiates European Lyme Borrelia species."
97
+ }
98
  ]
99
+ }